Malaysia's biotech sector exceeds investment target of RM9bil


PUCHONG: The local biotechnology industry, facilitated by Malaysian Biotechnology Corp Sdn Bhd (BiotechCorp), has accrued a total investment of RM12bil since 2011, surpassing the Government’s five-year target under the National Biotechnology Policy (NBP).

The policy, currently in its second phase, had originally aimed to achieve RM9bil in investments by the end of 2015. The first five-year phase attracted RM5.4bil.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , BiotechCorp , BioNexus , BioShoppe , Nova , MOSTI

   

Next In Business News

Wall St set to open higher on tech boost, PCE data
US inflation rises in line with expectations in March
Gamuda Land announces retail partners for Gamuda Gardens
YNH reaffirms bondholders with remedied technical defaults
Ringgit ends firmer against US dollar
KPJ Healthcare partners with Trustr for AI-driven healthcare solutions
Homeritz stays positive amid economic challenges
Unisem expects performance boost amid semiconductor recovery
Gadang wins RM280mil data centre contract
S P Setia unveils Casaville single-storey bungalows in Setia EcoHill, Semenyih

Others Also Read